ETF Managers Group’s Filana Therapeutics FLNA Stock Holding History

ETF Managers Group’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-20,360	Closed	-$895K	–	776
2021 Q1	$895K	Buy	+20,360	New	+$801K	0.02%	289

Other funds holding FLNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

ETF Managers Group's FLNA Position: Q2 2021 in Review

ETF Managers Group sold out of Filana Therapeutics (FLNA) in Q2 2021, closing a stake of 20,360 shares — an estimated $895K sold.

ETF Managers Group first reported a position in FLNA in Q1 2021 and held it in 1 quarter. The position peaked at $895K in Q1 2021. 169 funds tracked by Wall St. Rank hold FLNA as of Q2 2021.

ETF Managers Group reported no remaining Filana Therapeutics position as of Q2 2021 after selling out during the quarter.
ETF Managers Group sold 20,360 Filana Therapeutics shares in Q2 2021, an estimated $895K.
ETF Managers Group first reported a position in Filana Therapeutics in Q1 2021 and held it in 1 quarter.
ETF Managers Group's Filana Therapeutics position peaked at $895K in Q1 2021.
169 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2021.

Based on ETF Managers Group's 13F filing for Q2 2021, filed 16 Aug 2021.